Tekmira Pharmaceuticals Corporation Call Advisory 2008 Audited Results and Corporate Update

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 18, 2009) - Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it will hold a conference call and webcast on Tuesday March 24, 2009 at 9:00 am Pacific Time (12:00 noon Eastern Time) to discuss 2008 audited financial results and to provide a corporate update.

About the Conference Call

To participate in the conference call, please dial 416-340-8018 or 1-866-225-0198. The call will be available for replay until April 7, 2009 by calling 416-695-5800 or 1-800-408-3053 and entering the code 2868442.

The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

The Equicom Group - Investors
Adam Peeler
(416) 815-0700 x 225
Email: apeeler@equicomgroup.com

Tekmira Pharmaceuticals Corporation
Ian Mortimer
Executive Vice President and Chief Financial Officer
(604) 419-3200
Website: www.tekmirapharm.com

Longview Communications Inc. - Media
David Ryan
(604) 694-6031
Email: dryan@longviewcomms.ca

Back to news